Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1R lipoic acid1件: Lipoic acid1件: Thioctic acid 💬 --1件: 13 💬
2R(+) pramipexole dihydrochloride monohydrate----1件: 2 💬
3R-(-)-1-(benzofuran-2-YL)-2-propylaminopentane hydrochloride----1件: 6 💬
4R-2487----2件: 46, 53 💬
5R-3750----1件: 97 💬
6R-ATG----1件: 60 💬
7R-HIL-18BP----1件: 65 💬
8R-methugdnf1件: Liatermin1件: Liatermin 💬 --1件: 6 💬
9R-methuleptin1件: Metreleptin1件: Metreleptin 💬 1件: LEPR 💬 7件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
10R-pact----1件: 113 💬
11R-roscovitine1件: Seliciclib---1件: 75 💬
12R-salbutamol sulphate1件: Levosalbutamol1件: Levosalbutamol 💬 1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 49 💬
13R03ac02----1件: 299 💬
14R03cc02----1件: 299 💬
15R05C B01----1件: 299 💬
16R05cb01----1件: 193 💬
17R3r011件: R3R01---2件: 218, 222 💬
18R727----1件: 79 💬
19R788----2件: 46, 63 💬
20R788 sodium hexahydrate, RIG2-01, RIG-G----1件: 46 💬
21R788 sodium, R788 NA, R788----1件: 46 💬
22R788, fostamatinib disodium hexahydrate (IN uspi/FPI)1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
23R932333----1件: 49 💬
24R935788----4件: 46, 61, 63, 66 💬
25RA101495----1件: 62 💬
26RA101495 sodium----1件: 62 💬
27RA15804589, C19061501-F, DNL788, DN2489, DN0002489----2件: 2, 13 💬
28Raav 2/6 hids donor----1件: 19 💬
29RAAV-GAD----1件: 6 💬
30RAAV-OLIG001-aspa1件: MYR-101---1件: 307 💬
31Raav.HPDE6A vector ----1件: 90 💬
32RAAV1-CB-haat1件: rAAV1-CB-hAAT---1件: 231 💬
33RAAV1-CMV-GAA (study agent) administration----1件: 256 💬
34RAAV1.CMV.hufollistatin344----2件: 15, 113 💬
35RAAV1.CMV.hufollistin344----1件: 113 💬
36RAAV1.tmck.human-alpha-sarcoglycan- first cohort----1件: 113 💬
37RAAV1.tmck.human-alpha-sarcoglycan- second cohort----1件: 113 💬
38RAAV2-CB-haat gene vector----1件: 231 💬
39RAAV2-ND11件: NFS-02---1件: 302 💬
40RAAV2-ND4----1件: 302 💬
41RAAV2/2-ND4 vector----1件: 302 💬
42RAAV2/5-hnaglu----1件: 19 💬
43RAAV2/5-pbgd vector dosage 1----1件: 254 💬
44RAAV2/5-pbgd vector dosage 2----1件: 254 💬
45RAAV2/5-pbgd vector dosage 3----1件: 254 💬
46RAAV2/5-pbgd vector dosage 4----1件: 254 💬
47RAAV2/6 left ZFN vector----1件: 19 💬
48RAAV2/6 right ZFN vector----1件: 19 💬
49RAAV2TYF-GRK1-hrpgrco1件: Laruparetigene zovaparvovec---1件: 90 💬
50RAAV2TYF-GRK1-rpgr1件: Laruparetigene zovaparvovec---1件: 90 💬
51RAAV5-mihtt1件: AMT-130---1件: 8 💬
52RAAV8-DES-HMTM1----1件: 111 💬
53RAAV8-HMD1----1件: 113 💬
54RAAV9-CB6-aspa----1件: 307 💬
55RAAV9-CK8-H-µD51件: Zildistrogene varoparvovec---1件: 113 💬
56RAAV9-hfkrpco_mir-208A----1件: 113 💬
57RAAV9.CMV.hnaglu----1件: 19 💬
58Raavrh74.MCK.galgt2----1件: 113 💬
59Raavrh74.MCK.micro-dystrophin----1件: 113 💬
60Rabbit1件: Rabbit---5件: 11, 13, 60, 96, 285 💬
61Rabbit ANTI-human thymocyte immunoglobulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬2件: 13, 96 💬
62Rabbit ANTI-thymocyte globulin1件: Rabbit---4件: 49, 65, 285, 326 💬
63Rabbit antithymocyte globulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬3件: 49, 60, 96 💬
64Rabbit ATG2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬4件: 60, 62, 283, 285 💬
65Rabbit ATG, cyclosporine, levamisole2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬1件: 60 💬
66Rabbit human T lymphocyte immunoglobulin1件: Rabbit---2件: 13, 60 💬
67Rabeprazole1件: Rabeprazole3件: Rabeprazole sodium ,
Clofezone ,
Rabeprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 2, 51 💬
68Rabeximod1件: Rabeximod---1件: 46 💬
69Raclopride1件: Raclopride---1件: 6 💬
70RAD001----6件: 34, 67, 89, 96, 158, 228 💬
71RAD001 1MG----1件: 158 💬
72RAD001 2,5 MG----1件: 158 💬
73RAD001 5MG----2件: 89, 158 💬
74RAD001 round tablets----1件: 158 💬
75RAD001, everolimus----1件: 34 💬
76RAD001: everolimus----1件: 34 💬
77RAD011----1件: 193 💬
78Radamts-131件: Apadamtase alfa2件: Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		1件: ADAMTS13 💬 1件: Platelet activation 💬1件: 64 💬
79Radamts13----1件: 64 💬
80Radiation therapy----6件: 13, 34, 60, 65, 284, 285 💬
81Radiofrequency----1件: 46 💬
82Radiofrequency ablation----1件: 58 💬
83Radiographic evaluation----1件: 34 💬
84Radiographs OF THE thoracic and lumbar spine----1件: 162 💬
85Radiolabelled oligog CF-5/20 6% solution----1件: 299 💬
86Radiolabelled oligog CF-5/20 6% solution FOR nebulisation----1件: 299 💬
87Radiolabelled oligog CF-5/20 DPI----1件: 299 💬
88Radiopharmaceuticals----1件: 5 💬
89Radiosurgical thalamotomy----1件: 6 💬
90Radiotherapy----1件: 77 💬
91Radiotracer [11C]-CS1p1----1件: 13 💬
92Radiotracer [11C]-DPA-713----1件: 13 💬
93Radiotracer [12F]-FDG----1件: 13 💬
94Radiotracer injection----2件: 94, 96 💬
95Radiprodil1件: Radiprodil---3件: 137, 145, 158 💬
96Radiprodil + CO-administered drugs1件: Radiprodil---2件: 137, 158 💬
97Radiprodil with carbamazepine1件: Radiprodil---2件: 137, 158 💬
98Radiprodil with itraconazole1件: Radiprodil---2件: 137, 158 💬
99Radotinib HCL 50 MG1件: Radotinib---1件: 6 💬
100RAG-171件: RAG-17---1件: 2 💬
101Rahf1件: Antihemophilic factor, human recombinant1件: Octocog alfa 💬 1件: F8 💬 1件: Complement and coagulation cascades 💬1件: 288 💬
102Ralenova----1件: 13 💬
103Ralinepag1件: Ralinepag1件: Ralinepag 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
104Raloxifene1件: Raloxifene2件: Raloxifene hydrochloride ,
Raloxifene 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 77 💬
105Raloxifene hydrochloride1件: Raloxifene2件: Raloxifene hydrochloride ,
Raloxifene 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46 💬
106Raltegravir1件: Raltegravir2件: Raltegravir ,
Raltegravir potassium 💬 		--4件: 13, 26, 93, 265 💬
107Raltegravir and zidovudine1件: Raltegravir2件: Raltegravir ,
Raltegravir potassium 💬 		--1件: 26 💬
108Ramatroban1件: Ramatroban1件: Ramatroban 💬 2件: PTGDR,
TBXA2R 💬 		3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬1件: 13 💬
109Ramelteon1件: Ramelteon1件: Ramelteon 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 8, 46 💬
110Ramipril1件: Ramipril1件: Ramipril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 46, 49, 66, 67, 113, 218, 257 💬
111Ramosetron1件: Ramosetron2件: Ramosetron hydrochloride ,
Ramosetron 💬 		5件: HTR3,
HTR3,
HTR3,
HTR3,
HTR3 💬 		3件: Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬1件: 97 💬
112Randomized B-fructan diet----1件: 97 💬
113Ranexa1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
114Ranibizumab1件: Ranibizumab1件: Ranibizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬4件: 34, 166, 227, 301 💬
115Ranidil - 50 MG/5 ML soluzione iniettabile PER USO endovenoso 10 fiale----1件: 28 💬
116Ranitidina1件: Ranitidine3件: Ranitidine ,
Ranitidine hydrochloride ,
Ranitidine bismuth citrate 💬 		1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 28 💬
117Ranitidine1件: Ranitidine3件: Ranitidine ,
Ranitidine hydrochloride ,
Ranitidine bismuth citrate 💬 		1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 13, 65 💬
118Rankl/OPG ratio----1件: 49 💬
119Ranolazina ranexa1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
120Ranolazine1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--7件: 2, 58, 86, 96, 97, 113, 114 💬
121Ranolazine 1000 MG1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 2 💬
122Ranolazine 1000 MG PR tablets1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
123Ranolazine 500 MG1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 2 💬
124Ranolazine 500 MG PR tablets1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
125Ranolazine 750 MG PR tablets1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
126Ranolazine PR (prolonged-release) 500 MG 1 tablet BIS IN DIE and 750 MG 1 tablet BIS IN DIE1件: Ranolazine2件: Ranolazine ,
Ranolazine hydrochloride 💬 		--1件: 58 💬
127RAPA-501 autologous T stem cells----1件: 2 💬
128Rapamune1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬7件: 60, 66, 67, 84, 158, 278, 280 💬
129Rapamune - 1 MG 100 compresse rivestite IN blister USO orale----1件: 2 💬
130Rapamune 0.5 MG coated tablets----1件: 280 💬
131Rapamune 1 MG/ML oral solution----3件: 137, 158, 280 💬
132Rapamune 1 MG/ML solucióN oral----1件: 158 💬
133Rapamune 1MG tablets1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
134Rapamune 1MG/ML oral solution----1件: 137 💬
135Rapamune*100CPR RIV 1MG1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
136Rapamune*30CPR RIV 1MG1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
137Rapamune*30CPR RIV 2MG1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
138Rapamycin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬19件: 2, 15, 34, 35, 46, 49, 51, 53, 60, 61, 63, 67, 86, 96, 158, 193, 256, 279, 283 💬
139Rapamycin cream, topical, 0.5%, 1.0% W/W1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
140Rapamycin, sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
141Rapamycin-calcitriol combination1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 49件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
142Rapcabtagene autoleucel----3件: 43, 44, 51 💬
143Rapcabtagene autoleucel regimen 1----1件: 49 💬
144Rapcabtagene autoleucel regimen 2----1件: 49 💬
145Rapeglinide----1件: 299 💬
146Rapeseed OIL----1件: 79 💬
147Rapid dose titration group OF subcutaneous treprostinil----1件: 86 💬
148Raptiva1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬3件: 37, 49, 53 💬
149Raptiva 100 MG/ML powder and solvent FOR solution FOR injection1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬8件: 11, 13, 46, 53, 61, 95, 96, 221 💬
150RAS----1件: 66 💬
151RAS 2410----1件: 66 💬
152RAS inhibitor----1件: 66 💬
153Rasagilin----2件: 5, 6 💬
154Rasagilina mesilato1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
155Rasagiline1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬4件: 2, 5, 6, 17 💬
156Rasagiline 0.75 MG1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
157Rasagiline 1 MG capsule1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
158Rasagiline 1MG tablet1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
159Rasagiline 2 MG tablet1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
160Rasagiline mesilate1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬3件: 2, 5, 6 💬
161Rasagiline mesylate1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
162Rasagiline mesylate 1.0 MG1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
163Rasagiline mesylate plus mirapex1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
164Rasagiline mesylate with levodopa1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
165Rasagiline mesylate with requip1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
166Rasagiline tablets1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
167Ratg1件: Antithymocyte immunoglobulin (rabbit)1件: Anti-human thymocyte immunoglobulin, rabbit 💬 11件: CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬 		31件: Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬4件: 13, 51, 60, 285 💬
168Ravagalimab1件: Ravagalimab1件: Ravagalimab 💬 1件: TNFRSF5 💬 17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬3件: 46, 53, 97 💬
169Ravicti1件: Glycerol phenylbutyrate1件: Glycerol phenylbutyrate 💬 --2件: 7, 251 💬
170Ravicti 1.1 G/ML----1件: 7 💬
171Ravicti high dose----1件: 299 💬
172Ravicti LOW dose----1件: 299 💬
173Ravpal-PEG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
174Ravpal-PEG 0.001 MG/KG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
175Ravpal-PEG 0.003 MG/KG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
176Ravpal-PEG 0.01 MG/KG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
177Ravpal-PEG 0.03 MG/KG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
178Ravpal-PEG 0.1 MG/KG1件: Pegvaliase1件: Pegvaliase 💬 1件: phhA 💬 3件: Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
179Ravulizumab1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
180Ravulizumab obds1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
181Raxone1件: Idebenone1件: Idebenone 💬 --2件: 113, 302 💬
182Raxone - 150 MG- compresse rivestite CON FILM- USO orale- flacone (hdpe)- 180 compresse1件: Idebenone1件: Idebenone 💬 --1件: 113 💬
183RAY121----2件: 50, 162 💬
184Rayos1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
185Rbatg----2件: 51, 96 💬
186RC18 160 MG----2件: 13, 53 💬
187RC18 160 MG plus MTX----1件: 46 💬
188RC18 160 MG plus standard therapy----1件: 49 💬
189RC18 160MG----3件: 11, 13, 66 💬
190RC18 240 MG----2件: 11, 53 💬
191RC18 240 MG plus standard therapy----1件: 49 💬
192RC18 240MG----2件: 13, 66 💬
193RC18 80 MG plus standard therapy----1件: 49 💬
194RCT11001件: RCT1100---1件: 340 💬
195RCT2100----1件: 299 💬
196RCTB-401----2件: 96, 97 💬
197RD06-04 cart cell injection----3件: 49, 51, 53 💬
198RD06-04 cells injection----1件: 49 💬
199RD06-04 or RD06-05 cart cell injection----2件: 51, 53 💬
200RD06-05 cart cell injection----2件: 13, 51 💬
201RD13-02----1件: 60 💬
202RDD TO palynziq----1件: 240 💬
203RDP581件: RDP58---1件: 97 💬
204RE-021----3件: 66, 218, 222 💬
205RE-024----1件: 121 💬
206Reaction time and postural control----1件: 299 💬
207Reactive corticosteroid taper regimen----1件: 251 💬
208Reading tutoring intervention----1件: 34 💬
209Reagila----1件: 21 💬
210REAL-time data capture APP----1件: 46 💬
211Rebamipide1件: Rebamipide1件: Rebamipide 💬 --4件: 46, 53, 97, 271 💬
212Rebamipide mouthwash1件: Rebamipide1件: Rebamipide 💬 --1件: 56 💬
213Rebif1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
214Rebif (interferon BETA-1A), merck serono europe LTD2件: Human interferon beta,
Interferon beta-1a		2件: Interferon beta ,
Interferon beta-1a 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
215Rebif 221件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
216Rebif 22 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
217Rebif 22 Y 44 MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
218Rebif 441件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
219Rebif 44 microgrammi/0.5ML soluzione iniettabile IN cartuccia----1件: 13 💬
220Rebif 44 microgramos solucióN inyectable----1件: 13 💬
221Rebif 44 microgramos solucióN inyectable EN jeringa precargada----1件: 13 💬
222Rebif 44 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
223Rebif 44 micrograms solution FOR injection1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
224Rebif 44 micrograms solution FOR injection IN PRE-filled syringe1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
225Rebif 44 µG----1件: 13 💬
226Rebif 8,8 µG, rebif 22µG----1件: 13 💬
227Rebif 8.8 micrograms and 22 micrograms solution FOR injection IN PRE-filled syringe initiation pack1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
228Rebif NEW formulation + ibuprofen PRN----1件: 13 💬
229Rebif NEW formulation + prophylactic ibuprofen----1件: 13 💬
230Rebif NEW formulation 44MCG multidose cartridge1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
231Rebif NEW formulation NON titrated----1件: 13 💬
232Rebif NEW formulation titrated----1件: 13 💬
233Rebif SC 12SIR 12000000ui44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
234Rebif SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
235Rebif*SC 12SIR 12000000ui44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
236Rebif*SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
237Rebif® NEW formulation----1件: 13 💬
238Rebif® NEW formulation (RNF) using rebismarttm----1件: 13 💬
239Rebisufligene etisparvovec1件: Rebisufligene etisparvovec---1件: 19 💬
240Reblozyl1件: Luspatercept1件: Luspatercept 💬 1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 282 💬
241REC-2282----1件: 34 💬
242REC-H-FGF19----1件: 94 💬
243Received hormone maintenance therapy----1件: 96 💬
244Recifercept1件: Recifercept1件: Recifercept 💬 1件: FGFR3 💬 12件: Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬1件: 276 💬
245Recombinant A disintegrin and metalloproteinase thrombospondin TYPE-1 motifs 13----1件: 64 💬
246Recombinant A disintegrin and metalloproteinase with thrombospondin TYPE-1 motifs----1件: 64 💬
247Recombinant A disintegrin and metalloproteinase with thrombospondin TYPE-1 motifs 13----1件: 64 💬
248Recombinant AAV vector serotype 2 containing THE human wild type mitochondrial ND4 gene----1件: 302 💬
249Recombinant AAV vector serotype 2 containing THE human wild typemitochondrial ND4 gene----1件: 302 💬
250Recombinant AAV-9 vector expressing THE human progranulin protein----1件: 127 💬
251Recombinant activated factor VII----1件: 288 💬
252Recombinant adamts13----1件: 64 💬
253Recombinant adeno-associated viral vector expressing THE human alpha-1-antitrypsin gene----1件: 231 💬
254Recombinant adeno-associated viral vector serotype 2.7m8 containing THE chrimsonr-tdtomato gene----1件: 90 💬
255Recombinant adeno-associated virus 2/6 vector encoding THE cdna FOR human alpha galactosidase A----1件: 19 💬
256Recombinant adeno-associated virus acid alpha-glucosidase----1件: 256 💬
257Recombinant adenovirus containing THE ornithine transcarbamylase gene----1件: 251 💬
258Recombinant alpha-galactosidase A1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
259Recombinant antihumanized ANTI-human monoclonal antibody directed against THE IL-6R----1件: 107 💬
260Recombinant coagulation fviii FC – VON willebrand factor – xten fusion protein1件: Von Willebrand factor human---1件: 288 💬
261Recombinant coagulation fviii FC –VON willebrand factor – xten fusion protein1件: Von Willebrand factor human---1件: 288 💬
262Recombinant DNA-derived human growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 187 💬
263Recombinant factor FC fusion protein----2件: 46, 49 💬
264Recombinant factor xiii----1件: 288 💬
265Recombinant granulocyte - colony stimulating factor----1件: 39 💬
266Recombinant growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 96 💬
267Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-MAN6 glycan----1件: 256 💬
268Recombinant human acid sphingomyelinase----1件: 19 💬
269Recombinant human ALFA-glucosidase conjugated with synthetic bismannose-6-phosphate-MAN6 glycan----1件: 256 💬
270Recombinant human alpha B-crystallin----1件: 13 💬
271Recombinant human alpha-galactosidase----1件: 19 💬
272Recombinant human alpha-galactosidase abbreviated AS R-H-alpha-GAL----1件: 19 💬
273Recombinant human alpha-mannosidase----1件: 19 💬
274Recombinant human angiotensin-converting enzyme 2 (ACE2), APN011件: Alunacedase alfa---1件: 86 💬
275Recombinant human anti IL-22 monoclonal antibody IGG1----1件: 46 💬
276Recombinant human ANTI-GDF-8 antibody----1件: 113 💬
277Recombinant human apolipoprotein----1件: 79 💬
278Recombinant human apolipoprotein A-I/phospholipids complex----1件: 79 💬
279Recombinant human apolipoprotein A1----1件: 79 💬
280Recombinant human arylsulfatase A1件: Recombinant human arylsulfatase A---1件: 19 💬
281Recombinant human arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
282Recombinant human beta glucuronidase----1件: 19 💬
283Recombinant human BETA-glucuronidase1件: Vestronidase alfa1件: Vestronidase alfa 💬 1件: uidA 💬 6件: Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
284Recombinant human betaglucuronidase----1件: 19 💬
285Recombinant human C1 esterase inhibitor----1件: 65 💬
286Recombinant human C1 inhibitor1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
287Recombinant human cerebral dopamine neurotrophic factor1件: HER-902---1件: 6 💬
288Recombinant human coagulation factor viii FC - VON willebrand facto1件: Antihemophilic factor human---1件: 288 💬
289Recombinant human coagulation factor viii FC - VON willebrand factor - xten fusion protein----1件: 288 💬
290Recombinant human coagulation factor viii FC - VON willebrand factor -xten fusion protein2件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
291Recombinant human derived macrophage-targeted ß-glucocerebrosidase----1件: 19 💬
292Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused TO THE FC fragment OF IGG1----1件: 166 💬
293Recombinant human erythropoietin1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 13 💬
294Recombinant human glucerebrosidase----1件: 19 💬
295Recombinant human glucocerebrosidase----1件: 19 💬
296Recombinant human growth hormon----1件: 193 💬
297Recombinant human growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 77, 193, 265, 276 💬
298Recombinant human growth hormone (rhgh) injection1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 193 💬
299Recombinant human growth hormone + rosiglitazone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265 💬
300Recombinant human heparan N-sulfatase----1件: 19 💬
301Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--3件: 14, 28, 65 💬
302Recombinant human hyaluronidase + immune globulin intravenous1件: Hyaluronidase (human recombinant)1件: Hyaluronidase 💬 --1件: 65 💬
303Recombinant human IFN beta----1件: 13 💬
304Recombinant human IGF-1----1件: 299 💬
305Recombinant human insulin-like growth factor----1件: 96 💬
306Recombinant human interferon beta1件: Human interferon beta1件: Interferon beta 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
307Recombinant human interferon BETA-1A----1件: 26 💬
308Recombinant human interleukin-21件: Aldesleukin1件: Aldesleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 35 💬
309Recombinant human interleukin-7----1件: 25 💬
310Recombinant human lysosomal acid lipase----1件: 19 💬
311Recombinant human lysosomal alpha-mannosidase----1件: 19 💬
312Recombinant human MAB OF IGG4 subtype----1件: 46 💬
313Recombinant human monoclonal antibody----1件: 46 💬
314Recombinant human monoclonal antibody TO human IL-1beta OF THE IGG1/K class----3件: 106, 107, 108 💬
315Recombinant human monoclonal antibody TO IL-17 OF THE IGG1-K-class----1件: 271 💬
316Recombinant human monoclonal antibody TO inerleukin-1beta OF THE IGG1-K-class----1件: 46 💬
317Recombinant human monoclonal antibody TO interleukin-1beta OF THE IGG1-kappa-class----1件: 46 💬
318Recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
319Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110----1件: 19 💬
320Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 1101件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
321Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance1件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
322Recombinant human pentraxin-21件: Zinpentraxin alfa1件: Zinpentraxin alfa 💬 --1件: 85 💬
323Recombinant human porphobilinogen deaminase1件: Porphobilinogen deaminase, human recombinant---1件: 254 💬
324Recombinant human somatotropin----1件: 236 💬
325Recombinant human thrombopoietin1件: Recombinant Human Thrombopoietin---1件: 63 💬
326Recombinant human tripeptidyl peptidase-11件: Cerliponase alfa1件: Cerliponase alfa 💬 1件: TPP1 💬 1件: Lysosome 💬1件: 19 💬
327Recombinant human VON willebrand factor----1件: 288 💬
328Recombinant humanised ANTI-human monoclonal antibody directed against THE IL-6R----1件: 46 💬
329Recombinant humanized ANTI-alpha 4 integrin antibody----1件: 13 💬
330Recombinant humanized ANTI-CD20 monoclonal antibody----1件: 13 💬
331Recombinant humanized ANTI-human interleukin 6-receptor (IL-6R) monoclonal----1件: 46 💬
332Recombinant humanized ANTI-human interleukin 6-receptor (IL-6R) monoclonal antibody----1件: 46 💬
333Recombinant humanized ANTI-human interleukin-6----1件: 46 💬
334Recombinant humanized ANTI-human interleukin-6 receptor (IL-6R) monoclonal antibody----1件: 46 💬
335Recombinant humanized ANTI-human monoclonal antibody directed against THE IL-6R----3件: 46, 51, 107 💬
336Recombinant humanized ANTI-interleukin-6 receptor monoclonal antibody injection----1件: 46 💬
337Recombinant humanized ANTI-interleukin-6 receptor monoclonal antibody injection 4MG/KG----1件: 331 💬
338Recombinant humanized ANTI-interleukin-6 receptor monoclonal antibody injection 6MG/KG----1件: 331 💬
339Recombinant humanized ANTI-interleukin-6 receptor monoclonal antibody injection 8MG/KG----1件: 331 💬
340Recombinant humanized IGG4 monoclonal antibody----1件: 61 💬
341Recombinant humanized monoclonal antibody omalizumab TO IGE1件: Omalizumab1件: Omalizumab 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
342Recombinant humanized monoclonal antibody specific FOR human IL-5----1件: 44 💬
343Recombinant humanized monoclonal antibody TO IL-6R----1件: 46 💬
344Recombinant interferon alfa----2件: 26, 28 💬
345Recombinant interferon BE----1件: 13 💬
346Recombinant interferon BETA-1B2件: Human interferon beta,
Interferon beta-1b		2件: Interferon beta-1b ,
Interferon beta 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
347Recombinant interleukin-111件: Oprelvekin1件: Oprelvekin 💬 1件: IL11RA 💬 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
348Recombinant lcat----1件: 259 💬
349Recombinant microbial lipase----1件: 298 💬
350Recombinant microbial lipase SLV339----1件: 298 💬
351Recombinant neisseria meningitidis group B fhbp fusion protein produced IN E.coli cells BY recombinant DNA technology adsorbed ON aluminium hydroxide----1件: 11 💬
352Recombinant neisseria meningitidis group B nada protein----1件: 11 💬
353Recombinant neisseria meningitidis group B nhba fusion protein----2件: 11, 13 💬
354Recombinant SELF-complementary adeno-associated viral vector serotype 9 containing THE human CLN6 gene----1件: 19 💬
355Recombinant somatropin----1件: 193 💬
356Recombinant TNF-A receptor: IGG FC fusion protein----2件: 46, 271 💬
357Recombinant truncated spint2 protease inhibitor1件: Ulinastatin1件: Ulinastatin 💬 6件: CTRB,
CTRB,
ELANE,
PRSS1_2_3,
PRSS1_2_3,
PRSS1_2_3 💬 		7件: Influenza A, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pancreatic secretion, Protein digestion and absorption, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬1件: 299 💬
358Recombinant VON willebrand factor----1件: 288 💬
359Recombinant VON willebrand factor 1300IU1件: Von Willebrand factor human---1件: 288 💬
360Recombinant VON willebrand factor 650IU1件: Von Willebrand factor human---1件: 288 💬
361Recombinant zoster vaccine----2件: 13, 49 💬
362Recombinant-methionyl human glial cell LINE-derived neurotrophic factor----1件: 6 💬
363Recomibnant human VON willebrand factor----1件: 288 💬
364Recommendation with regard TO nutrition----1件: 6 💬
365Recording OF vital signs----1件: 172 💬
366Rectal dialysis----1件: 97 💬
367Rectal tacrolimus----1件: 97 💬
368Rectosigmoidoscopy----1件: 97 💬
369RED blood cell ZN----1件: 299 💬
370Redasemtide1件: Redasemtide---1件: 36 💬
371Reditux----1件: 46 💬
372Reduced dose OF cyclophosphamide combined with standard immunosuppressive therapy----1件: 60 💬
373Reduced glutathione1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬 		--2件: 6, 299 💬
374Reduced glutathione 100MG----1件: 6 💬
375Reduced glutathione 200MG----1件: 6 💬
376Reduced glutathione sodium salt----1件: 299 💬
377Reduced intensity allogeneic hematopoietic stem cell transplantation----1件: 51 💬
378Reduced intensity allogeneic transplant----2件: 49, 51 💬
379Reduced intensity conditioning----2件: 19, 65 💬
380Reduced intensity preparative regimen----3件: 62, 65, 284 💬
381Reduced toxicity ablative regimen----3件: 62, 65, 284 💬
382Reduced-dose conditioning regimen containing TBI IN hematopoietic stem cell transplantation treating elderly patients with aplastic anemia----1件: 60 💬
383Reduction group 1----1件: 46 💬
384Reduction group 2----1件: 46 💬
385REF cruzada PEI Nº 12-088----1件: 274 💬
386Refered TO general practice----1件: 46 💬
387Reference capsule GDC-0134----1件: 2 💬
388Reference medicinal product----1件: 46 💬
389Reference product----1件: 46 💬
390Refresh endura----1件: 53 💬
391Regadenoson1件: Regadenoson2件: Regadenoson ,
Regadenoson 💬 		1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 58 💬
392Rege PRO dressing----1件: 36 💬
393Regend001----1件: 85 💬
394Regimen selection phase group 2----1件: 113 💬
395Regimen selection phase group 3----1件: 113 💬
396REGN1500----1件: 79 💬
397REGN1500 250 MG SC/15 MG/KG IV/450 MG SC----1件: 79 💬
398REGN2477----1件: 272 💬
399REGN2477+REGN1033----1件: 15 💬
400REGN3918----2件: 11, 62 💬
401REGN4461----1件: 265 💬
402REGN475/SAR164877----1件: 298 💬
403REGN7257----1件: 60 💬
404REGN881件: Sarilumab1件: Sarilumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
405Regular exercise----1件: 113 💬
406Regular novolin R----1件: 6 💬
407Regular treatment----1件: 97 💬
408Regulatory T cells----2件: 95, 97 💬
409REH-acteoside----1件: 66 💬
410Rehabilitation therapy----1件: 6 💬
411Relacorilant1件: Relacorilant1件: Relacorilant 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 75 💬
412Relaxin----1件: 51 💬
413Reldesemtiv1件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 2 💬
414Reldesemtiv 150 MG1件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 3 💬
415Reldesemtiv 450 MG1件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 3 💬
416Relma-CEL1件: Relmacabtagene autoleucel---2件: 49, 51 💬
417Relovade----1件: 63 💬
418Remestemcel-L1件: Remestemcel-L1件: Remestemcel-L 💬 --2件: 96, 97 💬
419Remibrutinib1件: Remibrutinib1件: Remibrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 11, 13, 53 💬
420Remibrutinib oral treatment1件: Remibrutinib1件: Remibrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
421Remicade1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬8件: 46, 49, 56, 84, 85, 96, 97, 271 💬
422Remicade - 100 MG polvere PER concentrato PER infusione endovenosa 1 flacone vetro 20 ML USO EV1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
423Remicade 100 MG1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 56, 96, 97 💬
424Remicade 100 MG infuusiokuiva-aine, konsentraattiliuosta varten1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
425Remicade 100 MG polvo para concentrado para solucióN para perfusióN1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
426Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning----4件: 46, 96, 97, 271 💬
427Remicade*EV F 100MG+F 2ML1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
428Remifentanil1件: Remifentanil2件: Remifentanil hydrochloride ,
Remifentanil 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 6, 22, 70 💬
429Remifentanyl1件: Remifentanil2件: Remifentanil hydrochloride ,
Remifentanil 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 6 💬
430Remimazolam1件: Remimazolam2件: Remimazolam besylate ,
Remimazolam 💬 		16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6 💬
431Reminder capsules----1件: 19 💬
432Reminder product----1件: 19 💬
433Reminyl----1件: 6 💬
434Reminyl retard----1件: 6 💬
435Remisma----1件: 96 💬
436Remodulin1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
437Remodulin 10MG/ML 20ML1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
438Remodulin 1MG/ML 20ML1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
439Remodulin 2.5MG/ML 20ML1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
440Remodulin 5MG/ML 20ML1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
441Remodulin® (treprostinil) 1 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
442Remodulin® (treprostinil) 10 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
443Remodulin® (treprostinil) 2.5 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
444Remodulin® (treprostinil) 5 MG/ML solution FOR infusion1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
445Remsima1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
446Remsima 100 MG powder FOR solution FOR infusion1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
447Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning----4件: 46, 96, 97, 271 💬
448Remsima 120 MG solution FOR injection IN PRE-filled syringe1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
449Remsima and inflectra1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
450Remsima IV----2件: 46, 271 💬
451Remsima SC----2件: 46, 271 💬
452Remsina----1件: 96 💬
453REN0011件: ReN001---1件: 256 💬
454Renadirsen1件: Renadirsen---1件: 113 💬
455Renal sympathetic denervation----1件: 67 💬
456Renishaw drug delivery system----1件: 6 💬
457Repagermanium1件: Propagermanium1件: Propagermanium 💬 --1件: 222 💬
458Repaglinide1件: Repaglinide1件: Repaglinide 💬 2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬3件: 6, 21, 299 💬
459Repaglinide and insulin1件: Repaglinide1件: Repaglinide 💬 2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 299 💬
460Repaglinide tablets1件: Repaglinide1件: Repaglinide 💬 2件: ABCC8,
KCNJ11 💬 		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 46 💬
461Repair OF CDH W/alloderm----1件: 294 💬
462Repair OF CDH W/SIS gold----1件: 294 💬
463Reparixin1件: Reparixin1件: Reparixin 💬 2件: CXCR1,
CXCR2 💬 		7件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬2件: 298, 299 💬
464Repatha 140 MG solution FOR injection IN PRE-filled PEN1件: Evolocumab1件: Evolocumab 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
465Repatha 420 MG solution FOR injection IN cartridge1件: Evolocumab1件: Evolocumab 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
466Repatha 420 MG soluzione PER iniezione IN cartuccia1件: Evolocumab1件: Evolocumab 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬1件: 79 💬
467Replagal1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
468Replagal agalsidase alfa1件: Agalsidase alfa1件: Agalsidase alfa 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
469Repository corticotropin injection1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 2, 13, 46, 84, 222 💬
470Repository corticotropin injection -treatment extension----1件: 84 💬
471Reproxalap1件: Reproxalap1件: Reproxalap 💬 --1件: 160 💬
472Requip1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309 💬
473Requip modutab, 2MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
474Requip modutab, 4MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
475Requip modutab, 8MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
476Requip PR----1件: 6 💬
477Requip prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
478Requip XL prolonged-release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
479Requip*21CPR 0,25MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
480Requip*21CPR 0,5MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
481Requip*21CPR 1MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
482Requip*21CPR 5MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
483Requip-LP1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
484Requip-modutab1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
485Requip-modutab , 2MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
486Requip-modutab , 4MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
487Requip-modutab , 8MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
488Requip-modutab, 2MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
489Requip-modutab, 4MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
490Requip-modutab, 8MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
491Rescue medication cdca 250 MG TID1件: Chenodeoxycholic acid1件: Chenodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 263 💬
492Rescue WLL----1件: 229 💬
493Research testing performed----1件: 46 💬
494Resistance exercise----1件: 299 💬
495Resistance exercise program----1件: 46 💬
496Resistance training----1件: 6 💬
497Resistant maltodextrin1件: Maltodextrin1件: Maltodextrin 💬 --1件: 6 💬
498Resistant starch----1件: 6 💬
499Resistive respiratory loads----1件: 6 💬
500Reslizumab1件: Reslizumab1件: Reslizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 98 💬
501Resolor*28CPR RIV 2MG1件: Prucalopride2件: Prucalopride ,
Prucalopride succinate 💬 		1件: HTR4 💬 5件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 51 💬
502RESP3011件: RESP301---1件: 299 💬
503RESP302----1件: 299 💬
504RESP303----1件: 299 💬
505Respiratory and exercise therapy with supplemental oxygen----1件: 88 💬
506Respiratory symptom questionnaire: criss----1件: 299 💬
507Response TO anakinra associated with methotrexate----1件: 46 💬
508Response TO infliximab associated with methotrexate----1件: 46 💬
509Rest OF ANA profile----1件: 49 💬
510Restasis1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 53, 162 💬
511Restex tabletten----1件: 6 💬
512Restricted phenylalanine diet----1件: 240 💬
513Resunab, ajulemic acid, anabasum1件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
514Resveratrol1件: Resveratrol---5件: 8, 18, 89, 113, 299 💬
515Resveratrol supplementation1件: Resveratrol---1件: 97 💬
516Retarded release phosphatidylcholine----1件: 97 💬
517Retigabine1件: Ezogabine1件: Ezogabine 💬 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 2 💬
518Retigabine/ezogabine1件: Ezogabine1件: Ezogabine 💬 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 144 💬
519Retinal pigment epitheliums transplantation----1件: 90 💬
520Retinoic acid receptor gamma agonist1件: Tretinoin1件: Tretinoin 💬 3件: PML,
RARA,
RARB 💬 		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 231 💬
521Retrospective case only----1件: 172 💬
522Retrospective evaluation OF endoscopy prior TO study drug----1件: 98 💬
523Retrovir1件: Zidovudine1件: Zidovudine 💬 --1件: 135 💬
524Retroviral SF71-GP91phox transduced CD34+ cells----1件: 65 💬
525Retrovirus construct----1件: 285 💬
526Retrovirus-mediated gene transfer----1件: 65 💬
527RETT-T----1件: 156 💬
528Reumaflex----1件: 107 💬
529Revamilast1件: Revamilast---1件: 46 💬
530Revascularization/conservative management----1件: 22 💬
531Revatio1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
532Revatio - 0.8 MG/ML - soluzione iniettabile - USO endovenoso - flaconcino(vetro) 1 flaconcino DA 20 ML1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
533Revatio 0.8MG/ML solution FOR injection1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
534Revatio 10 MG/ML powder FOR oral suspension1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
535Revatio 20 MG1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 85 💬
536Revatio 20 MG film coated tablets1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
537Revatio 20 MG FILM-coated tablets----1件: 86 💬
538Revatio 20 MG filmtabletten1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
539Revatio 20 MG, comprimidos recubiertos CON PELícula1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
540Revatio inyectable1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
541Revatio oral1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
542Revatio POS1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
543Revatio tablets1件: Sildenafil2件: Sildenafil citrate ,
Sildenafil 💬 		1件: PDE5 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
544Revaxis----1件: 13 💬
545Reveglucosidase alfa1件: Reveglucosidase alfa---1件: 256 💬
546Reveglucosidase alpha----1件: 256 💬
547Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir----1件: 325 💬
548Revlimid1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
549Revlimid*21CPS 25MG1件: Lenalidomide1件: Lenalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
550Revolade1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
551Revolade - 25 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU) 28 compresse1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 60 💬
552Revolade - 50 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 60 💬
553Revolade 25 MG FILM-coated tablets1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
554Revolade 50 MG FILM-coated tablets1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
555Revolade 75 MG1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 60 💬
556Revolade, promacta1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
557Revusiran1件: Revusiran---1件: 28 💬
558REX robotic assisted balance exercises----1件: 13 💬
559Rexlemestrocel-L1件: Rexlemestrocel-L---2件: 210, 211 💬
560Reyataz1件: Atazanavir2件: Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
561Reyataz 150MG 60 CPS BL1件: Atazanavir2件: Atazanavir sulfate ,
Atazanavir 💬 		--1件: 265 💬
562RF catheter ablation----1件: 58 💬
563RFB002----1件: 166 💬
564RFB002, rhufab V21件: Ranibizumab1件: Ranibizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 166 💬
565RFB002A----1件: 166 💬
566RFP----1件: 338 💬
567Rfviia, rfviia + TXA1件: Coagulation factor VIIa Recombinant Human1件: Eptacog alfa 💬 1件: F7 💬 1件: Complement and coagulation cascades 💬1件: 288 💬
568Rfviii----1件: 288 💬
569RG-012----1件: 218 💬
570RG012----1件: 218 💬
571RG6042, formerly isis 443139, ionis-httrx----1件: 8 💬
572RGB-03----1件: 46 💬
573RGH-706----1件: 193 💬
574RGH-706 hydrochloride----1件: 193 💬
575RGLS4326----1件: 67 💬
576RGLS8429----1件: 67 💬
577RGX-1111件: RGX-111---1件: 19 💬
578RGX-1211件: RGX-121---1件: 19 💬
579RGX-2021件: RGX-202---1件: 113 💬
580RH growth hormone----1件: 19 💬
581Rharsa----1件: 19 💬
582Rhasa----1件: 19 💬
583Rhasa - dose level 1----1件: 19 💬
584Rhasa - dose level 2----1件: 19 💬
585Rhasa - dose level 3----1件: 19 💬
586Rhasa [recombinant human arylsulfatase A], formerly HGT-1110, NOW also known AS TAK-611----1件: 19 💬
587Rhasm----1件: 19 💬
588RHB-104----2件: 13, 96 💬
589Rhbssl1件: Bucelipase alfa---1件: 299 💬
590RHC1IHN----1件: 65 💬
591RHC1INH----1件: 65 💬
592RHC1INH or PDC1INH----1件: 65 💬
593Rhdnase----1件: 299 💬
594Rheopheresis treatment----1件: 51 💬
595Rhepo----1件: 13 💬
596Rhgaa----1件: 256 💬
597Rhgaa, acid alpha glucosidase----1件: 256 💬
598Rhgalns1件: Elosulfase alfa1件: Elosulfase alfa 💬 1件: GALNS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
599Rhgh1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬5件: 76, 96, 193, 246, 337 💬
600RHGM-CSF1件: Regramostim1件: Regramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
601Rhgus----1件: 19 💬
602Rhhns1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
603Rhhns-10 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
604Rhhns-45 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
605Rhhns-90 MG1件: Heparan-N-sulfatase (human, recombinant)---1件: 19 💬
606Rhifn BETA-1B----1件: 13 💬
607Rhigf-1----1件: 156 💬
608Rhigf-1/rhigfbp-3----1件: 195 💬
609Rhigf-I/rhigfbp-3----1件: 113 💬
610Rhigm22----1件: 13 💬
611RHIL-11----2件: 96, 97 💬
612Rhlaman1件: Velmanase alfa1件: Velmanase alfa 💬 1件: MAN2B1 💬 2件: Lysosome, Other glycan degradation 💬1件: 19 💬
613Rhnaglu----1件: 19 💬
614Rhnaglu radiolabelled----1件: 19 💬
615Rhnaglu-IGF21件: Tralesinidase alfa---1件: 19 💬
616Rhngf 180 µG/ML EYE drops solution----1件: 90 💬
617Rhngf 60 µG/ML EYE drops solution----1件: 90 💬
618Rhpth1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTHR2 💬 		4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬3件: 70, 235, 326 💬
619Rhtpo1件: Recombinant Human Thrombopoietin---2件: 60, 63 💬
620Rhtpo combined with herombopag + CSA1件: Recombinant Human Thrombopoietin---1件: 60 💬
621Rhtpo IN combination with rituximab1件: Recombinant Human Thrombopoietin---1件: 63 💬
622Rhucd40L----1件: 65 💬
623Rhudex 100 MG (127 MG rhudex choline salt) granules----1件: 93 💬
624Rhudex 25 MG (31.75 MG rhudex choline salt) granules----1件: 93 💬
625Rhudex 50 MG (63.5 MG rhudex choline salt) granules----1件: 93 💬
626RHUG-CSF----1件: 18 💬
627Rhumab 2h71件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
628Rhumab BETA7----1件: 97 💬
629Rhumab BETA7, anti beta 7, PRO145223----1件: 97 💬
630Rhumab BETA7, anti BETA7, PRO145223----1件: 97 💬
631Rhumab ifnalpha----1件: 49 💬
632Rhumab TO IL-17A IGG1-K-class----1件: 13 💬
633Rhuph20----2件: 13, 14 💬
634Rhustoxicodendron 30----1件: 46 💬
635Rhutnfr:FC----2件: 46, 271 💬
636RI-002----1件: 65 💬
637Ribavirin1件: Ribavirin1件: Ribavirin 💬 --2件: 2, 96 💬
638Ribazen----1件: 46 💬
639Ribitol1件: Ribitol1件: Ribitol 💬 --1件: 113 💬
640Riboflavin1件: Riboflavin1件: Riboflavin 💬 --7件: 13, 38, 46, 97, 162, 168, 265 💬
641Riboflavin sodium phosphate injection1件: Riboflavin1件: Riboflavin 💬 --1件: 96 💬
642Riboflavin supplementation1件: Riboflavin1件: Riboflavin 💬 --1件: 96 💬
643RIC----1件: 22 💬
644RIC allobmt W ptcy IN refractory SSC----1件: 51 💬
645Rice/turkey free diet (R/TFD) group1件: Rice---1件: 53 💬
646Riciguat group----1件: 86 💬
647Rifabutin1件: Rifabutin1件: Rifabutin 💬 --1件: 96 💬
648Rifabutin, clarithromycin, and clofazimine1件: Rifabutin1件: Rifabutin 💬 --1件: 96 💬
649Rifampicin1件: Rifampin2件: Rifampin ,
Rifampicin sodium 💬 		--8件: 6, 13, 17, 46, 93, 97, 299, 338 💬
650Rifampin1件: Rifampin2件: Rifampin ,
Rifampicin sodium 💬 		--4件: 13, 84, 86, 299 💬
651Rifampin 300MG BID + istradefylline 40MG DAY 8 only2件: Istradefylline,
Rifampin		3件: Rifampin ,
Istradefylline ,
Rifampicin sodium 💬 		1件: ADORA2A 💬 8件: Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
652Rifaximin1件: Rifaximin1件: Rifaximin 💬 --8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
653Rifaximin 550 MG1件: Rifaximin1件: Rifaximin 💬 --1件: 6 💬
654Rifaximin delayed release 400 MG film coated tablet1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
655Rifaximin delayed release tablets1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
656Rifaximin EIR1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
657Rifaximin oral tablet1件: Rifaximin1件: Rifaximin 💬 --1件: 99 💬
658Rifaximin+omeprazole+miralax1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
659Rifaximin-EIR1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
660Rifaximina1件: Rifaximin1件: Rifaximin 💬 --1件: 96 💬
661Rigerimod----1件: 49 💬
662Right heart catheterization (RHC) while exercising----1件: 86 💬
663Rigosertib1件: Rigosertib2件: Rigosertib ,
Rigosertib sodium 💬 		1件: PLK1 💬 4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
664Rigosertib oral capsules / rigosertib intravenous1件: Rigosertib2件: Rigosertib ,
Rigosertib sodium 💬 		1件: PLK1 💬 4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
665Rigosertib sodium1件: Rigosertib2件: Rigosertib ,
Rigosertib sodium 💬 		1件: PLK1 💬 4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
666RIL-1RA----1件: 107 💬
667Riliprubart1件: Riliprubart1件: Riliprubart 💬 1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
668Rilmenidine1件: Rilmenidine1件: Rilmenidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8 💬
669Rilonacept1件: Rilonacept1件: Rilonacept 💬 2件: IL1A,
IL1B 💬 		44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬5件: 51, 84, 106, 107, 266 💬
670Rilonacept 160 MG1件: Rilonacept1件: Rilonacept 💬 2件: IL1A,
IL1B 💬 		44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
671Rilutek1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 13, 203 💬
672Rilutek 50 MG FILM-coated tablets1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
673Rilutek 50 MG, FILM-coated tablets1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
674Riluzole1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬8件: 2, 3, 5, 8, 13, 17, 203, 206 💬
675Riluzole 100MG/DAY1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
676Riluzole 50 MG1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
677Riluzole oral soluble film1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
678Riluzole oral soluble film (rosf) 50 MG1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
679Riluzole tablet1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
680Riluzolo----1件: 2 💬
681Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC----1件: 114 💬
682Rilzabrutinib1件: Rilzabrutinib1件: Rilzabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 35, 61, 63, 222, 300 💬
683Rilzabrutinib oral tablet1件: Rilzabrutinib1件: Rilzabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 35 💬
684Rimacalib1件: Rimacalib---1件: 46 💬
685Rimactan----1件: 299 💬
686Rimegepant1件: Rimegepant2件: Rimegepant ,
Rimegepant sulfate 💬 		1件: CALCRL 💬 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
687Rimeporide1件: Rimeporide---1件: 113 💬
688Rimiducid1件: Rimiducid1件: Rimiducid 💬 1件: CASP9 💬 34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬7件: 19, 49, 60, 65, 284, 285, 326 💬
689Rimonabant1件: Rimonabant1件: Rimonabant 💬 1件: CNR1 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193 💬
690Rimso 50----1件: 226 💬
691Ringer lactate----1件: 51 💬
692Rinvoq1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
693Riocigu----1件: 51 💬
694Riociguat1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 51, 84, 86, 88, 225, 299 💬
695Riociguat 0.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
696Riociguat 1.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
697Riociguat 1.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
698Riociguat 2.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
699Riociguat 2.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
700Riociguat coated tablet 0.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
701Riociguat coated tablet 1.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
702Riociguat coated tablet 1.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
703Riociguat coated tablet 2.0 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
704Riociguat coated tablet 2.5 M1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
705Riociguat coated tablet 2.5 MG1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
706Riociguat film coated tablets1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
707Riociguat granules 0.3% FOR oral application1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
708Riociguat oral product1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
709Riociguat oral tablet1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
710Riociguat pill1件: Riociguat1件: Riociguat 💬 3件: GUCY1A,
GUCY1A,
GUCY1B 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
711Ripertamab1件: Ripertamab---1件: 14 💬
712RIPK1 inhibitor----1件: 13 💬
713Riquent----1件: 49 💬
714Risankizumab1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬4件: 37, 96, 97, 271 💬
715Risankizumab 10 MG/ML1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
716Risankizumab 180 MG SC1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
717Risankizumab 600 MG IV1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
718Risankizumab 90 MG/ML1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
719Risankizumab IV1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
720Risankizumab SC1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
721Risankizumab-800CW 15 MG1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
722Risankizumab-800CW 25 MG1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
723Risankizumab-800CW 4.5 MG1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
724Risankizumab-800CW optimal dose1件: Risankizumab1件: Risankizumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
725Risdiplam1件: Risdiplam1件: Risdiplam 💬 --1件: 3 💬
726Risedronate1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 46, 66, 96 💬
727Risedronate oral tablet1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
728Risedronate sodium1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬4件: 50, 107, 113, 274 💬
729Risedronate sodium 2.5MG1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
730Risedronate sodium 5MG1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
731Risedronato Sódico 2.5MG----1件: 274 💬
732Risedronato Sódico 5MG----1件: 274 💬
733Risedronic acid1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
734Risperdal----1件: 203 💬
735Risperidone1件: Risperidone1件: Risperidone 💬 2件: DRD2,
HTR2 💬 		13件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬3件: 8, 156, 187 💬
736Risperidone 1MG TAB1件: Risperidone1件: Risperidone 💬 2件: DRD2,
HTR2 💬 		13件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 8 💬
737RIST4721----1件: 266 💬
738Ritalin1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
739Ritalin LA 20MG capsules1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
740Ritalin LA 30MG capsules1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
741Ritalin LA 40MG capsules1件: Methylphenidate2件: Methylphenidate hydrochloride ,
Methylphenidate 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
742Ritivixibat1件: Ritivixibat---1件: 94 💬
743Ritlecitinib1件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬1件: 97 💬
744Ritlecitinib 10 MG1件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬1件: 97 💬
745Ritlecitinib 5 MG1件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬1件: 97 💬
746Ritlecitinib 50 MG1件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬2件: 96, 97 💬
747Ritlecitinib 50MG1件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬1件: 96 💬
748Ritlecitinib/JAK 31件: Ritlecitinib1件: Ritlecitinib tosylate 💬 1件: JAK3 💬 15件: Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬1件: 46 💬
749Ritonavir1件: Ritonavir1件: Ritonavir 💬 --3件: 2, 86, 265 💬
750Rituxan1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬7件: 35, 46, 60, 61, 63, 256, 288 💬
751Rituxan (INN: rituximab), brand name IN THE united states1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
752Rituxan (INN: rituximab), brand name IN THE US1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
753Rituxan, cyclophosphamide, vincristine, prednisone1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
754Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
755Rituximab - mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
756Rituximab 1G IV1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
757Rituximab 1G/6months1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
758Rituximab 200MG/6months1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
759Rituximab and cyclophosphamide IV1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 35 💬
760Rituximab and dexamethasone1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
761Rituximab and hyaluronidase human1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 331 💬
762Rituximab combined with corticosteroids1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
763Rituximab combined with omalizumab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
764Rituximab combined with tacrolimus induction + rituximab maintenance1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
765Rituximab combined with tacrolimus induction + tacrolimus maintenance1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
766Rituximab infusion1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 13, 222 💬
767Rituximab injection1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 35, 222 💬
768Rituximab IT1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
769Rituximab IV1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
770Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
771Rituximab mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
772Rituximab, cyclophosphamide, and corticosteroids1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
773Rituximab, mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 53 💬
774Rituximab, MTX, folic acid1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
775Rituximab, observational study amon patients with active RA1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
776Rituximab-EU+ rituximab-pfizer X 2 courses1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
777Rituximab-pfizer1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
778Rituximab-pfizer (PF-05280586) X 3 courses1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
779Rituximab-US + rituximab-pfizer X 2 courses1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
780Rituximab/ mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 271 💬
781RIV-TDS 13.3 MG/24 H----1件: 6 💬
782Rivaroxaban1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬5件: 46, 49, 91, 210, 271 💬
783Rivaroxaban 20 MG1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 91 💬
784Rivaroxaban plus immunosupression1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 56 💬
785Rivastigmin----1件: 13 💬
786Rivastigmin luye transdermal patches - 4.6MG/24H----1件: 6 💬
787Rivastigmine1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 5, 6 💬
788Rivastigmine capsule1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
789Rivastigmine CF1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
790Rivastigmine luye transdermal patch- 9.5MG/24H1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
791Rivastigmine patch 9.5 CM21件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
792Rivastigmine transdermal patch1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 13 💬
793Rivastigmine transdermal system1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
794Rivastigmine transdermal system 13.3 MG/24 H1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
795Rivenprost1件: Rivenprost---1件: 97 💬
796Rivogenlecleucel1件: Rivogenlecleucel1件: Rivogenlecleucel 💬 --6件: 19, 60, 65, 284, 285, 326 💬
797Rivogenleucleucel----3件: 60, 285, 326 💬
798Rixathon1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
799Rixathon 500 MG----1件: 85 💬
800Rixathon 500MG----1件: 43 💬
801Rizankisumab----1件: 96 💬
802Rizankizumab----1件: 96 💬
803RJK002 intrathecal injection----1件: 2 💬
804RLY-26081件: RLY-2608---3件: 138, 278, 281 💬
805RM-131----1件: 6 💬
806RM-493----2件: 193, 202 💬
807Rmst----1件: 256 💬
808RN624, RI624----1件: 226 💬
809RNA analysis----3件: 28, 60, 97 💬
810RNA antisense oligonucleotide FOR intravitreal injection----2件: 90, 303 💬
811RNA sequencing----1件: 84 💬
812RNF----1件: 13 💬
813RNS60----2件: 2, 13 💬
814RNS60 125 ML----1件: 13 💬
815RNS60 250 ML----1件: 13 💬
816RO 001-9265/F02----1件: 41 💬
817RO 001-9265/F02-01----1件: 46 💬
818RO 001-9265/F03----1件: 41 💬
819RO 001-9265/F04----1件: 41 💬
820RO 002-9893/F02----1件: 46 💬
821RO 106-1443----1件: 49 💬
822RO 45-2294----1件: 46 💬
823RO 47-0203----4件: 51, 85, 86, 88 💬
824RO 48-77533----1件: 46 💬
825RO 487-533/F01----1件: 271 💬
826RO 487-5733/F01----1件: 271 💬
827RO 487-7533----1件: 46 💬
828RO 487-7533/F01----3件: 46, 107, 271 💬
829RO 487-7533/F10----2件: 46, 107 💬
830RO 487-7533/F10-02----1件: 46 💬
831RO 487-7533/F10-04----4件: 41, 46, 51, 107 💬
832RO 491-7523/F18----1件: 206 💬
833RO 491-7523/F19----1件: 206 💬
834RO 496-4913----2件: 46, 49 💬
835RO 496-4913/F03----2件: 13, 46 💬
836RO 496-4913/F07----1件: 13 💬
837RO 5072759----1件: 49 💬
838RO 533-3787/F01- 06----1件: 13 💬
839RO 533-3787/F01-06----1件: 11 💬
840RO 549-0261/F04----1件: 97 💬
841RO 549-0261/F04-02----1件: 96 💬
842RO 549-0261/F08-02----1件: 96 💬
843RO 551-6922----1件: 46 💬
844RO 723-4292/F02----1件: 8 💬
845RO actemra1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
846RO-47-0203----1件: 86 💬
847RO-47-0203/029----1件: 86 💬
848RO-496-4913----1件: 46 💬
849RO-actemra1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
850RO001-9265/F04----1件: 46 💬
851RO0029893----1件: 46 💬
852RO0220912----1件: 85 💬
853RO0280296----1件: 85 💬
854RO045-2294----1件: 46 💬
855RO0452294/V01----2件: 43, 44 💬
856RO0452294/V02----3件: 35, 43, 44 💬
857RO0485337----1件: 222 💬
858RO04877533----1件: 46 💬
859RO04877533/F05/F04----1件: 46 💬
860RO0506997----2件: 13, 46 💬
861RO106-1443----1件: 43 💬
862RO1061443/F02----1件: 35 💬
863RO3300074----1件: 231 💬
864RO4402257----1件: 46 💬
865RO45-2294----1件: 271 💬
866RO452294/V02----1件: 46 💬
867RO487-7533----1件: 46 💬
868RO487-7533/F01-F05----1件: 46 💬
869RO487-7533/F10-04----2件: 46, 51 💬
870RO4877533----2件: 46, 107 💬
871RO4877533/F01----1件: 46 💬
872RO4877533/F04-F05----1件: 46 💬
873RO4917523----1件: 206 💬
874RO4917523 0.5 MG----1件: 206 💬
875RO4917523 1.5 MG----1件: 206 💬
876RO496-4913----1件: 46 💬
877RO4964913----1件: 13 💬
878RO4964913 F07----1件: 13 💬
879RO4964913/F03----1件: 13 💬
880RO4964913/F07----1件: 13 💬
881RO4964913/F07-01----1件: 13 💬
882RO5072759----1件: 222 💬
883RO5333787----2件: 11, 13 💬
884RO545-9072/F03----1件: 53 💬
885RO5459072----1件: 53 💬
886RO549-0261/F04-02----1件: 96 💬
887RO5490255/F01-02----1件: 85 💬
888RO5490261 / F02----1件: 97 💬
889RO5490261/F02----2件: 96, 97 💬
890RO5534262 emicizumab1件: Emicizumab1件: Emicizumab 💬 2件: F10,
F9 💬 		1件: Complement and coagulation cascades 💬1件: 288 💬
891RO6885247----1件: 3 💬
892RO6885247/F02----1件: 3 💬
893RO6885247/F03----1件: 3 💬
894RO7010939----1件: 13 💬
895RO7010939/F13----1件: 49 💬
896RO7034067----1件: 3 💬
897RO7034067 / F12----1件: 3 💬
898RO7034067 / F13----1件: 3 💬
899RO7034067/F06 + solvente (RO----1件: 3 💬
900RO7034067/F07 + solvente (RO----1件: 3 💬
901RO7034067/F12----1件: 3 💬
902RO7034067/F13----1件: 3 💬
903RO7046015----1件: 6 💬
904RO7046015/prasinezumab----1件: 6 💬
905RO7049665----2件: 95, 97 💬
906RO7049665/IGG-IL2/ IGG-IL2nd2----1件: 95 💬
907RO7090919----1件: 3 💬
908RO7112689----1件: 62 💬
909RO7112689/F01----1件: 62 💬
910RO7112689/F03-01----2件: 62, 109 💬
911RO7112689/F03-03----1件: 62 💬
912RO7112689/F03-10----2件: 62, 109 💬
913RO7121932 - MAD----1件: 13 💬
914RO7121932 IV - SAD----1件: 13 💬
915RO7121932 SC - SAD----1件: 13 💬
916RO7123520----1件: 46 💬
917RO7123520/F03-01----1件: 46 💬
918RO720-4239/F01-01----1件: 113 💬
919RO72042369/F03-01----1件: 3 💬
920RO7204239----2件: 3, 113 💬
921RO7204239/F01-01----1件: 3 💬
922RO7204239/F03-01----1件: 3 💬
923RO7234292----1件: 8 💬
924RO7239361----1件: 113 💬
925RO7246311----1件: 97 💬
926RO7248824----1件: 201 💬
927RO7248824/F02-01----1件: 201 💬
928RO7248824/F03-01 (diluent FOR RO7248824/F02-01----1件: 201 💬
929RO7303509----1件: 51 💬
930RO7486967----1件: 6 💬
931RO7490677----1件: 85 💬
932RO7490677 160 MG/8 ML----1件: 85 💬
933RO7490677 160 MG/8ML----1件: 85 💬
934RO7490677 160MG/8ML----1件: 85 💬
935RO7490677/ F01-02----1件: 85 💬
936RO7490677/F01-01----1件: 85 💬
937RO7490677/F01-02----1件: 85 💬
938RO7490677/F01-03----1件: 85 💬
939RO7494222 (SRP-9001)----1件: 113 💬
940RO7507062----1件: 49 💬
941RO7790121----2件: 96, 97 💬
942RO7837195----1件: 97 💬
943Roactemra1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬7件: 41, 44, 46, 51, 86, 107, 271 💬
944Roactemra - 162 MG - soluzione iniettabile - USO sottocutaneo - siringa preriempita 0,9ML (vetro) - 4 siringhe preriempite1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
945Roactemra - 20 MG/ML concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 4ML 1 flaconcino1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
946Roactemra 162 MG1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
947Roactemra 162 MG solution FOR injection IN PRE-filled syringe1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
948Roactemra 162 MG solution injectable EN seringue PRéremplie1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 56 💬
949Roactemra 162 MG soluzione iniettabile IN siringa preriempita1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 50 💬
950Roactemra 20 MG/ML concentrado para solucióN para perfusióN1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
951Roactemra 20 MG/ML concentrate FOR solution FOR infusion1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
952Roactemra 20 MG/ML, concentrado para solucióN para perfusióN1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 46, 107, 271 💬
953Roactemra 20MG/ML1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 40 💬
954Roactemra® 20MG/ML konzentrat1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
955Roactemra®EV 1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
956Roactemre----1件: 41 💬
957Roacterma----1件: 46 💬
958Roactmera----1件: 46 💬
959Roadmab----1件: 96 💬
960ROB 803----1件: 46 💬
961ROB 803 (9-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-B] quinoxali----1件: 46 💬
962ROB 803 12.5MG capsule----1件: 46 💬
963ROB 803 15MG capsule----1件: 46 💬
964ROB 803 25MG capsule----1件: 46 💬
965ROB 803 6.25MG capsule----1件: 46 💬
966ROB 803 6.5MG capsule----1件: 46 💬
967Rocuronium1件: Rocuronium1件: Rocuronium bromide 💬 16件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬 		16件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 296 💬
968Rocuronium bromide1件: Rocuronium1件: Rocuronium bromide 💬 16件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬 		16件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
969Rodatristat ethyl2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
970Rodatristat ethyl 300 MG tablet BID2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
971Rodatristat ethyl 600 MG BID2件: Rodatristat,
Rodatristat ethyl		2件: Rodatristat ,
Rodatristat ethyl 💬 		1件: TPH1_2 💬 3件: Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬1件: 86 💬
972Rofecoxib1件: Rofecoxib1件: Rofecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
973Roferon-A 3MIU----1件: 56 💬
974Roferon-A, 3MIU----1件: 56 💬
975Roferon-A, 4.5MIU----1件: 56 💬
976Roferon-A, 6MIU----1件: 56 💬
977Roflumilast1件: Roflumilast1件: Roflumilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬4件: 84, 97, 206, 299 💬
978Roflumilast oral tablet1件: Roflumilast1件: Roflumilast 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299 💬
979Rokan (R) novo 120 MG----1件: 18 💬
980Role OF dopamine----1件: 6 💬
981Rolipram1件: Rolipram1件: Rolipram 💬 4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13 💬
982Romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
983Romiplostim plus dexamethasone2件: Dexamethasone,
Romiplostim		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		2件: NR3C1,
TPOR 💬 		4件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
984Romiplostin----1件: 63 💬
985Romosozumab1件: Romosozumab1件: Romosozumab 💬 1件: SOST 💬 2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬2件: 46, 274 💬
986Rondoraptivon pegol1件: BT200---1件: 288 💬
987Rontalizumab1件: Rontalizumab1件: Rontalizumab 💬 13件: IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA,
IFNA 💬 		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
988ROP+L-dopa----1件: 6 💬
989Ropinirole1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 74 💬
990Ropinirole controlled-release (requip CR) FOR RLS1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
991Ropinirole CR 2MG tablet1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
992Ropinirole CR 8MG tablet1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
993Ropinirole hydrochloride1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309 💬
994Ropinirole hydrochloride prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
995Ropinirole immediate release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
996Ropinirole implant1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
997Ropinirole IR1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
998Ropinirole IR tablets1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
999Ropinirole monotherapy1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1000Ropinirole oral product1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1001Ropinirole PR, 2MG1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1002Ropinirole PR/XR1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1003Ropinirole PR/XR tablets1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1004Ropinirole prolonged release1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1005Ropinirole XL1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬 		3件: DRD2,
DRD3,
DRD4 💬 		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1006Ropinirole/L-dopa2件: Levodopa,
Ropinirole		3件: Levodopa ,
Ropinirole hydrochloride ,
Ropinirole 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1007Ropivacaine1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 22, 36, 46, 70, 97 💬
1008Ropivacaine hydrochloride injection1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
1009Ropivacaine plus normal saline1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
1010Ropivacaine, epinephrine, clonidine, and ketorolac injection cocktail1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
1011Roscovitine----1件: 299 💬
1012Rosemary essential OIL1件: Rosemary---1件: 51 💬
1013Rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 77, 97, 222 💬
1014Rosiglitazone extended release tablets1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 46 💬
1015Rosiglitazone maleate1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265 💬
1016Rosiglitazone XR1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 46 💬
1017Rosnilimab1件: Rosnilimab1件: Rosnilimab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 46, 97 💬
1018Rosuvastatin1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬9件: 6, 18, 46, 49, 51, 79, 94, 96, 271 💬
1019Rosuvastatin + BCX73532件: Berotralstat,
Rosuvastatin		4件: Rosuvastatin calcium ,
Rosuvastatin ,
Berotralstat ,
Berotralstat hydrochloride 💬 		2件: HMGCR,
KLKB1 💬 		4件: AMPK signaling pathway, Bile secretion, Complement and coagulation cascades, Terpenoid backbone biosynthesis 💬1件: 65 💬
1020Rosuvastatin 10 MG1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 96 💬
1021Rosuvastatin 10MG1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 97 💬
1022Rosuvastatin 20MG1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 79 💬
1023Rosuvastatin calcium1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬4件: 49, 79, 97, 299 💬
1024Rosuvastatin calcium 40MG1件: Rosuvastatin2件: Rosuvastatin calcium ,
Rosuvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 56 💬
1025Rosuvastatine EG----1件: 97 💬
1026ROT-TDS 8 MG/24 H----1件: 6 💬
1027Rotational thromboelastometry----2件: 86, 88 💬
1028Rotigotin----1件: 6 💬
1029Rotigotina1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 127 💬
1030Rotigotine1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 67, 127 💬
1031Rotigotine 4MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 127 💬
1032Rotigotine 6MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 127 💬
1033Rotigotine 8MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1034Rotigotine hydrochloride1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1035Rotigotine nasal spray1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1036Rotigotine transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1037Rotigotine, extended-release microspheres1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1038Routine----1件: 240 💬
1039Routine drainage surgery----1件: 96 💬
1040Routine MRI scan----1件: 75 💬
1041Routine steroid administration group----1件: 85 💬
1042Routine therapy----1件: 299 💬
1043Routine transdermal oestrogen patch----1件: 78 💬
1044Routine treatment----1件: 88 💬
1045Routine treatment OF CD----1件: 96 💬
1046Roxithromycin1件: Roxithromycin1件: Roxithromycin 💬 --2件: 46, 299 💬
1047Royal jelly1件: Royal jelly1件: Royal jelly 💬 --1件: 49 💬
1048Rozanolixizumab1件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
1049Rozerem1件: Ramelteon1件: Ramelteon 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
1050Rozibafusp alfa1件: Rozibafusp Alfa1件: Rozibafusp alfa 💬 2件: ICOSLG,
TNFSF13B 💬 		5件: Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
1051RP 103----2件: 8, 19 💬
1052RP-A5011件: RP-A501---1件: 32 💬
1053RP-L1021件: Mozafancogene autotemcel---1件: 285 💬
1054RP-L2011件: RP-L201---1件: 65 💬
1055RP103----2件: 8, 19 💬
1056RPC-1063----1件: 13 💬
1057RPC0163----1件: 96 💬
1058RPC1063----3件: 13, 96, 97 💬
1059RPC1063 (equivalent TO ozanimod1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
1060RPC4046----1件: 98 💬
1061RPH-1041件: Goflikicept---2件: 54, 266 💬
1062RPI78M FOR injection----1件: 20 💬
1063RPL554----1件: 299 💬
1064RPS 2505----2件: 246, 299 💬
1065RQ-00000010----1件: 6 💬
1066RS-baclofen----1件: 10 💬
1067RSLV-132----2件: 49, 53 💬
1068RSN0402 part 1----1件: 85 💬
1069RSN0402 part 2----1件: 85 💬
1070RSP-1502----1件: 299 💬
1071RSS0343 tabella----1件: 299 💬
1072RST-0011件: RST-001---1件: 90 💬
1073RT001----3件: 2, 5, 121 💬
1074RT234 - vardenafil inhalation powder----1件: 86 💬
1075RTA 402----3件: 67, 86, 218 💬
1076RTL10001件: RTL-1000---1件: 13 💬
1077RTNV148B IGG----3件: 46, 97, 271 💬
1078RTV----1件: 265 💬
1079RTX----3件: 13, 65, 222 💬
1080RTX-015----1件: 90 💬
1081RTX-134----1件: 240 💬
1082Rubidium1件: Rubidium---1件: 84 💬
1083Rubidium PET1件: Rubidium---1件: 84 💬
1084Ruconest1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
1085Ruconest - 2100 U - polvere PER soluzione iniettabile - USO endovenoso - flaconcino(vetro) 1 flaconcino DA 2100 U1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
1086Ruconest 2100 U powder FOR solution FOR injection1件: Conestat alfa1件: Conestat alfa 💬 3件: C1R,
C1S,
KLKB1 💬 		6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 65 💬
1087Rufinamide1件: Rufinamide1件: Rufinamide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144 💬
1088Rufinamide oral suspension1件: Rufinamide1件: Rufinamide 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144 💬
1089Rupatadine1件: Rupatadine2件: Rupatadine ,
Rupatadine fumarate 💬 		2件: HRH1,
PTAFR 💬 		5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬1件: 46 💬
1090Rurioctocog alfa pegol1件: Rurioctocog alfa pegol1件: Rurioctocog alfa pegol 💬 1件: F8 💬 1件: Complement and coagulation cascades 💬1件: 288 💬
1091Ruxience1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
1092Ruxolitinib1件: Ruxolitinib2件: Ruxolitinib ,
Ruxolitinib phosphate 💬 		2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 13, 15, 60, 65, 228 💬
1093Ruxolitinib 5 MG BID oral tablet1件: Ruxolitinib2件: Ruxolitinib ,
Ruxolitinib phosphate 💬 		2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 60 💬
1094Ruxolitinib topical cream1件: Ruxolitinib2件: Ruxolitinib ,
Ruxolitinib phosphate 💬 		2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 50 💬
1095RVA576----3件: 62, 109, 162 💬
1096RVG 03820----1件: 3 💬
1097RVG 05565----1件: 96 💬
1098RVG 07151----1件: 96 💬
1099RVG 08740----1件: 6 💬
1100RVG 08938----1件: 75 💬
1101RVG 101614----1件: 60 💬
1102RVG 104433----1件: 107 💬
1103RVG 105155----1件: 60 💬
1104RVG 114681----2件: 96, 97 💬
1105RVG 116648----2件: 96, 97 💬
1106RVG 13760----1件: 298 💬
1107RVG 15375----1件: 75 💬
1108RVG 18236----2件: 75, 227 💬
1109RVG 18388----1件: 160 💬
1110RVG 28636----1件: 107 💬
1111RVG 33865----1件: 86 💬
1112RVG 51680----1件: 14 💬
1113RVG 55618----1件: 6 💬
1114RVG 56083----1件: 14 💬
1115RVG00859----2件: 96, 97 💬
1116RVP-001----1件: 13 💬
1117RVT-101 35 MG----1件: 6 💬
1118RVT-1201----1件: 86 💬
1119RVT-1401----3件: 11, 14, 61 💬
1120RVT-1401, HL161BKN, HBM9161----1件: 11 💬
1121RVT-1601----1件: 85 💬
1122RVT-31011件: RVT-3101---1件: 96 💬
1123Rvwf----1件: 288 💬
1124RVX000222----1件: 19 💬
1125RWJ-445380 100 MG----1件: 46 💬
1126RWJ-445380 200 MG----1件: 46 💬
1127RWJ-445380 300 MG----1件: 46 💬
1128RWJ-445380 capsule 100 MG----1件: 46 💬
1129RWJ-445380 capsules 150 MG----1件: 46 💬
1130RWJ-445380 capsules 50 MG----1件: 46 💬
1131RWJ-445380-002----1件: 46 💬
1132RXC007----1件: 85 💬
1133RXC007 20 MG capsule----1件: 85 💬
1134RXC007 50 MG capsule----1件: 85 💬
1135Ry_sw01 cell injection----1件: 51 💬
1136RYAH-medtech inhaler----5件: 2, 6, 13, 96, 97 💬
1137RYR----1件: 46 💬
1138Rytary 145 MG----1件: 6 💬
1139Rytary 195 MG----1件: 6 💬
1140Répaglinide----1件: 299 💬